Related references
Note: Only part of the references are listed.Axonopathy in an α-Synuclein Transgenic Model of Lewy Body Disease Is Associated with Extensive Accumulation of C-Terminal Truncated α-Synuclein
Dora Games et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
A progressive dopaminergic phenotype associated with neurotoxic conversion of α-synuclein in BAC-transgenic rats
Silke Nuber et al.
BRAIN (2013)
Amyloid beta deregulates astroglial mGluR5-mediated calcium signaling via calcineurin and Nf-kB
Dmitry Lim et al.
GLIA (2013)
Metabotropic Glutamate Receptor 5 Is a Coreceptor for Alzheimer Aβ Oligomer Bound to Cellular Prion Protein
Ji Won Um et al.
NEURON (2013)
Amyloid-β and Alzheimer's disease type pathology differentially affects the calcium signalling toolkit in astrocytes from different brain regions
A. A. Grolla et al.
CELL DEATH & DISEASE (2013)
Cross-Seeding of Misfolded Proteins: Implications for Etiology and Pathogenesis of Protein Misfolding Diseases
Rodrigo Morales et al.
PLOS PATHOGENS (2013)
Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice
Kelvin C. Luk et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Cross-seeding effects of amyloid β-protein and α-synuclein
Kenjiro Ono et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Metabotropic glutamate receptors in neurodegeneration/neuroprotection: Still a hot topic?
Filippo Caraci et al.
NEUROCHEMISTRY INTERNATIONAL (2012)
Blockade of metabotropic glutamate receptors inhibits cognition and neurodegeneration in an MPTP-induced Parkinson's disease rat model
Ming-Hong Hsieh et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2012)
Examining the mechanisms that link beta-amyloid and alpha-synuclein pathologies
Samuel E. Marsh et al.
ALZHEIMERS RESEARCH & THERAPY (2012)
Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates Neurodegeneration
Daniel Zwilling et al.
CELL (2011)
Positive Allosteric Modulators of Type 5 Metabotropic Glutamate Receptors (mGluR5) and Their Therapeutic Potential for the Treatment of CNS Disorders
Richard M. Cleva et al.
MOLECULES (2011)
Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease
Eliezer Masliah et al.
PLOS ONE (2011)
Co-expression of C-terminal truncated alpha-synuclein enhances full-length alpha-synuclein-induced pathology
Ayse Ulusoy et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2010)
Synergistic Interactions between Aβ, Tau, and α-Synuclein: Acceleration of Neuropathology and Cognitive Decline
Lani K. Clinton et al.
JOURNAL OF NEUROSCIENCE (2010)
α-synuclein induced synapse damage is enhanced by amyloid-β1-42
Clive Bate et al.
MOLECULAR NEURODEGENERATION (2010)
Deleterious Effects of Amyloid β Oligomers Acting as an Extracellular Scaffold for mGluR5
Marianne Renner et al.
NEURON (2010)
Protective effect of metabotropic glutamate mGluR5 receptor elimination in a 6-hydroxydopamine model of Parkinson's disease
Yolanda D. Black et al.
NEUROSCIENCE LETTERS (2010)
Alterations in mGluR5 Expression and Signaling in Lewy Body Disease and in Transgenic Models of Alpha-Synucleinopathy - Implications for Excitotoxicity
Diana L. Price et al.
PLOS ONE (2010)
Calcium dyshomeostasis and neurotoxicity of Alzheimer's beta-amyloid protein
Masahiro Kawahara et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2009)
Beclin 1 Gene Transfer Activates Autophagy and Ameliorates the Neurodegenerative Pathology in α-Synuclein Models of Parkinson's and Lewy Body Diseases
Brian Spencer et al.
JOURNAL OF NEUROSCIENCE (2009)
Conditional transgenic mice expressing C-terminally truncated human α-synuclein (αSyn119) exhibit reduced striatal dopamine without loss of nigrostriatal pathway dopaminergic neurons
Joao Paulo L. Daher et al.
MOLECULAR NEURODEGENERATION (2009)
Brainstem Alzheimer's-like pathology in the triple transgenic mouse model of Alzheimer's disease
Cassia R. Overk et al.
NEUROBIOLOGY OF DISEASE (2009)
Statins reduce neuronal α-synuclein aggregation in in vitro models of Parkinson's disease
Pazit Bar-On et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Mechanisms of Hybrid Oligomer Formation in the Pathogenesis of Combined Alzheimer's and Parkinson's Diseases
Igor F. Tsigelny et al.
PLOS ONE (2008)
Different species of α-synuclein oligomers induce calcium influx and seeding
Karin M. Danzer et al.
JOURNAL OF NEUROSCIENCE (2007)
Calpain-cleavage of α-synuclein -: Connecting proteolytic processing to disease-linked aggregation
Brian M. Dufty et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
DLB and PDD boundary issues - Diagnosis, treatment, molecular pathology, and biomarkers
C. F. Lippa et al.
NEUROLOGY (2007)
Interaction between Aβ peptide and α synuclein:: Molecular mechanisms in overlapping pathology of Alzheimer's and Parkinson's in dementia with Lewy body disease
Pravat K. Mandal et al.
NEUROCHEMICAL RESEARCH (2006)
Selective dendritic degeneration of medium spiny neurons in dementia with Lewy bodies
S. Zaja-Milatovic et al.
NEUROLOGY (2006)
Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human α-synuclein (1-120):: Implications for Lewy body disorders
GK Tofaris et al.
JOURNAL OF NEUROSCIENCE (2006)
Design and cloning of lentiviral vectors expressing small interfering RNAs
Gustavo Tiscornia et al.
NATURE PROTOCOLS (2006)
The inhibition of glycogen synthase kinase 3β by a metabotropic glutamate receptor 5 mediated pathway confers neuroprotection to Aβ peptides
F Liu et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Impaired metabotropic glutamate receptor phospholipase C signaling pathway in the cerebral cortex in Alzheimer's disease and dementia with Lewy bodies correlates with stage of Alzheimer's-disease-related changes
JL Albasanz et al.
NEUROBIOLOGY OF DISEASE (2005)
Neuroprotective effects of metabotropic glutamate receptor ligands in a 6-hydroxydopamine rodent model of Parkinson's disease
AC Vernon et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Metabotropic glutamate receptors in the basal ganglia motor circuit
PJ Conn et al.
NATURE REVIEWS NEUROSCIENCE (2005)
Aβ deposition is associated with enhanced cortical α-synuclein lesions in Lewy body diseases
O Pletnikova et al.
NEUROBIOLOGY OF AGING (2005)
The role of metabotropic glutamate receptor 5 in learning and memory processes
A Simonyi et al.
DRUG NEWS & PERSPECTIVES (2005)
β-amyloid peptides impair PKC-dependent functions of metabotropic glutamate receptors in prefrontal cortical neurons
JP Tyszkiewicz et al.
JOURNAL OF NEUROPHYSIOLOGY (2005)
Cleavage of α-synuclein by calpain:: Potential role in degradation of fibrillized and nitrated species of α-synuclein
AJ Mishizen-Eberz et al.
BIOCHEMISTRY (2005)
Protection but maintained dysfunction of nigral dopaminergic nerve cell bodies and striatal dopaminergic terminals in MPTP-lesioned mice after acute treatment with the mGluR5 antagonist MPEP
JA Aguirre et al.
BRAIN RESEARCH (2005)
Block of long-term potentiation by naturally secreted and synthetic amyloid β-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5
QW Wang et al.
JOURNAL OF NEUROSCIENCE (2004)
Regulation by metabotropic glutamate receptor 5 of LTP in the dentate gyrus of freely moving rats: Relevance for learning and memory formation
K Naie et al.
CEREBRAL CORTEX (2004)
Endogenous activation of mGlu5 metabotropic glutamate receptors contributes to the development of nigro-striatal damage induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice
G Battaglia et al.
JOURNAL OF NEUROSCIENCE (2004)
MGLuR5 activation reduces β-amyloid-induced cell death in primary neuronal cultures and attenuates translocation of cytochrome c and apoptosis-inducing factor
VA Movsesyan et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Parkin cleaves intracellular α-synuclein inclusions via the activation of calpain
SJ Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Distinct cleavage patterns of normal and pathologic forms of α-synuclein by calpain I in vitro
AJ Mishizen-Eberz et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Glutamate receptors and Parkinson's disease - Opportunities for intervention
MJ Marino et al.
DRUGS & AGING (2003)
Differential neuropathological alterations in transgenic mice expressing α-synuclein from the platelet-derived growth factor and Thy-1 promoters
E Rockenstein et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Mechanism of membrane depolarization caused by the Alzheimer Aβ1-42 peptide
BJ Blanchard et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo
DM Walsh et al.
NATURE (2002)
Selective hippocampal neuron loss in dementia with Lewy bodies
AJ Harding et al.
ANNALS OF NEUROLOGY (2002)
Localization and physiological roles of metabotropic glutamate receptors in the direct and indirect pathways of the basal ganglia
MJ Marino et al.
AMINO ACIDS (2002)
Early formation of mature amyloid-β protein deposits in a mutant APP transgenic model depends on levels of Aβ1-42
E Rockenstein et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2001)
β-synuclein inhibits α-synuclein aggregation:: A possible role as an anti-parkinsonian factor
M Hashimoto et al.
NEURON (2001)
β-Amyloid peptides enhance α-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease
E Masliah et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Dopaminergic loss and inclusion body formation in α-synuclein mice:: Implications for neurodegenerative disorders
E Masliah et al.
SCIENCE (2000)
Share Paper
